Información del autor
Autor Garranzo Asensio, María |
Documentos disponibles escritos por este autor (6)
Añadir el resultado a su cesta Hacer una sugerencia Refinar búsqueda
texto impreso
Khodarahmi, Reza ; Torrente Rodríguez, Rebeca M. ; Ruiz-Valdepeñas Montiel, Víctor ; Campuzano, Susana ; Pedrero Muñoz, María ; Farchado, Meryem ; Vargas, Eva ; Manuel de Villena, F. Javier ; Garranzo Asensio, María ; Barderas, Rodrigo ; Pingarrón Carrazón, José Manuel | San Francisco, CA : Public Library of Science | 2017The first electrochemical immunosensor for the determination of fibroblast growth factor receptor 4 (FGFR4) biomarker is reported in this work. The biosensor involves a sandwich configuration with covalent immobilization of a specific capture an[...]texto impreso
texto impreso
Garranzo Asensio, María ; San Segundo Acosta, Pablo ; Povés Francés, Carmen ; Fernández Aceñero, María Jesús ; Martínez Useros, Javier ; Montero Calle, Ana ; Solís Fernández, Guillermo ; Sánchez Martínez, Mari Cruz ; Rodríguez, Nuria ; Cerón, María Ángeles ; Fernández Díez, Servando ; Domínguez Muñóz, Gemma ; Ríos, Vivian de los ; Peláez García, Alberto, Alberto ; Guzmán Aránguez, Ana Isabel ; Barderas, Rodrigo | Elsevier | 2020-03-01Colorectal cancer (CRC) is the third most common cancer and the second leading cause of cancer related death worldwide. Its diagnosis at early stages would significantly improve the survival of CRC patients. The humoral immune response has been [...]texto impreso
Garranzo Asensio, María ; San Segundo Acosta, Pablo ; Povés Francés, Carmen ; Fernández Aceñero, María Jesús ; Martínez Useros, Javier ; Montero Calle, Ana ; Solís Fernández, Guillermo ; Sánchez Martínez, Maricruz ; Rodríguez Salas, Nuria ; Cerón, María Ángeles ; Fernández Díez, Servando ; Domínguez Muñóz, Gemma ; Ríos, Vivian de los ; Peláez García, Alberto, Alberto ; Guzmán Aránguez, Ana Isabel ; Barderas Manchado, Rodrigo | Elsevier | 2020-03Colorectal cancer (CRC) is the third most common cancer and the second leading cause of cancer related death worldwide. Its diagnosis at early stages would significantly improve the survival of CRC patients. The humoral immune response has been [...]texto impreso
Garranzo Asensio, María ; Guzmán Aránguez, Ana Isabel ; Povedano, Eloy ; Ruiz Valdepeñas Montiel, Víctor ; Povés Francés, Carmen ; Fernández Aceñero, María Jesús ; Montero Calle, Ana ; Solís Fernández, Guillermo ; Fernández Díez, Servando ; Camps, Jordi ; Arenas, Meritxell ; Rodríguez Tomás, Elisabeth ; Joven, Jorge ; Sánchez Martínez, Maricruz ; Rodrígez, Nuria ; Domínguez Muñóz, Gemma ; Yáñez Sedeño, Paloma ; Pingarrón Carrazón, José Manuel ; Campuzano Ruiz, Susana ; Barderas Manchado, Rodrigo | Ivyspring International Publisher | 2020-02Background and Purpose: The humoral immune response in cancer patients can be used for early detection of the disease. Autoantibodies raised against tumor-associated antigens (TAAs) are promising clinical biomarkers for reliable cancer diagnosis[...]texto impreso
Garranzo Asensio, María ; Guzmán Aránguez, Ana Isabel ; Povés Francés, Carmen ; Fernández Aceñero, Mª Jesús ; Torrente Rodríguez, Rebeca Magnolia ; Ruiz Valdepeñas Montiel, Víctor ; Domínguez Muñóz, Gemma ; San Frutos Llorente, Luis ; Rodríguez Salas, Nuria ; Villalba Díaz, Mª Teresa (Mayte) ; Pingarrón Carrazón, José Manuel ; Campuzano Ruiz, Susana ; Barderas Manchado, Rodrigo | American Chemical Society | 2016-12-20Autoantibodies raised against tumor-associated antigens have shown high promise as clinical biomarkers for reliable diagnosis, prognosis, and therapy monitoring of cancer. An electrochemical disposable biosensor for the specific and sensitive de[...]